CCL4 and neoplasm: For example, mutations in the BRAF600E gene in melanoma can reduce the production of chemokines CCL3 and CCL4, thereby reducing the ability of tumor killing cells, M2-type TAMs mediate immune escape by secreting TNF-α and IL-10 in order to promote PD-L1 expression, thereby suppressing anti-tumor T cell function.